Current Opinion in Oncology
短名 | Curr. Opin. Oncol. |
Journal Impact | 2.88 |
国际分区 | ONCOLOGY(Q2) |
期刊索引 | SCI Q3中科院 4 区 |
ISSN | 1040-8746, 1080-8140, 1531-703X |
h-index | 104 |
国内分区 | 医学(4区)医学肿瘤学(4区) |
CURRENT OPINION IN ONCOLOGY 凭借其对世界文献重要进展的易于理解的评论,对来自 16 个重点学科(包括肉瘤、癌症生物学、黑色素瘤和内分泌肿瘤)的广泛主题进行了专家评估。每期出版双月刊,每期都详细介绍了上一年在这些领域中最相关的进展。附注的参考文献详细说明了最重要论文的优点,对此进行了补充。
期刊主页投稿网址涉及主题 | 医学生物内科学遗传学病理癌症肿瘤科外科化学生物化学免疫学癌症研究放射科化疗 |
出版信息 | 出版商: Lippincott Williams and Wilkins,出版周期: Bimonthly,期刊类型: journal |
基本数据 | 创刊年份: 1989,原创研究文献占比: 0.00%,自引率:0.00%, Gold OA占比: 10.34% |
平均审稿周期 | 网友分享经验:偏慢,4-8周 |
平均录用比例 | 网友分享经验:一般 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Lung cancer screening in never smokers
2024-9-10
The 5T's of health disparities in multiple myeloma in Latin America
2024-9-9
Perioperative immunotherapy in nonsmall cell lung cancer
2024-9-6
Achievements of international rare cancers networks and consortia in the neuro-oncology field
2024-8-29
Advances in the pathogenesis of FLT3-mutated acute myeloid leukemia and targeted treatments
2024-8-27
PARP inhibitor resistant BRCA-mutated advanced breast cancer: current landscape and emerging treatments
2024-8-23
Duodenal-type follicular lymphoma: comprehensive insights into disease characteristics and established treatment strategies
2024-8-23
When do I ask for a DNA methylation array for primary brain tumor diagnosis?
2024-8-23
Biomarker-directed therapy in multiple myeloma
2024-8-23
The emerging role of melflufen and peptide-conjugates in multiple myeloma
2024-8-22
Endocrine therapy for early breast cancer in the era of oral selective estrogen receptor degraders: challenges and future perspectives
2024-8-13
Immunotherapy in first line treatment of adult acute lymphoblastic leukemia
2024-8-13
Diligent use of MedDRA terminology and preferred term selection in safety reports of clinical trials
2024-8-8
Impact of sentinel node implementation in gynecologic cancers
2024-8-8
Editorial introductions
2024-8-6
Antibody-drug conjugates in metastatic breast cancer: sequencing, combinations and resistances
2024-8-6
Genomic tests for risk stratification in patients with early human epidermal growth factor receptor 2-positive breast cancer
2024-7-25
Role of sentinel lymph node biopsy with indocyanine green and site of injection in endometrial cancer
2024-7-18
Modeling the management of patients with human epidermal growth factor receptor 2-positive breast cancer with liquid biopsy: the future of precision medicine
2024-7-16
Chimeric antigen receptor adoptive immunotherapy in central nervous system tumors: state of the art on clinical trials, challenges, and emerging strategies to addressing them
2024-7-11
Liquid biopsy in brain tumors: moving on, slowly
2024-7-11
Patient-reported outcomes in neuro-oncology
2024-7-5
How to treat localized Hodgkin lymphoma?
2024-7-5
RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice
2024-7-5
Update of antibody–drug conjugates for hematological malignancies
2024-7-1
How to treat advanced Hodgkin lymphoma?
2024-6-26
Survivorship after Hodgkin lymphoma and the right to be forgotten
2024-6-25
Potential application of artificial intelligence in cancer therapy
2024-6-25
What is the best salvage therapy for Hodgkin lymphoma?
2024-6-21
Treatment approaches for older Hodgkin lymphoma patients
2024-6-21
Antibody-drug conjugates in solid tumors: a new frontier
2024-6-20
The role of signaling lymphocyte activation molecule family receptors in hematologic malignancies
2024-6-20
Different tracers for sentinel node detection in gynecologic oncology
2024-6-20
Impact of sentinel node use in lymphedema formation among gynecologic cancer patients
2024-6-18
The evolution of molecular management of carcinoma of unknown primary
2024-6-18
Implementation of sentinel node biopsy in high-risk endometrial cancer
2024-6-13
Novel PET tracers in breast cancer for treatment optimization: clinical utility and future perspectives
2024-6-13
Value of sentinel node ultrastaging and pathologic techniques in tumoral detection
2024-6-13
Benefits of sentinel node detection in cervical cancer
2024-6-13
Controversies on chemotherapy for early HR+/HER2− breast cancer: the role of anthracyclines and dose intensification
2024-6-13
Future of sentinel node biopsy in ovarian cancer
2024-6-12
Editorial introductions
2024-6-6
Beyond ‘the good, the bad and the ugly’: let us put rectal cancer patients at the centre of the decision making
2024-6-6
Health education in cancer patients: a renewed paradigm of “active” prevention
2024-6-6
Emerging therapies in Ewing sarcoma
2024-5-22
Interventions aiming to improve advance care planning uptake in oncology: a scoping review of recent randomized controlled trials
2024-5-9
Active surveillance and emerging medical treatment options for desmoid: when and for whom?
2024-5-7
State-of-the-art and trends in fibroblast growth factor receptor-directed therapies in gastro-intestinal malignancies
2024-5-7
New targeted therapies in liposarcoma: state of art and future perspectives
2024-5-7
State of the art and upcoming trends in HER2-directed therapies in gastrointestinal malignancies
2024-5-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远